Decreased hepatic drug metabolising enzyme activity in rats with nitrosamine-induced tumours

Drug Metabolism and Drug Interactions

Volumn 19, Issue 1, 2002, Pages 13-27

  Maliakal, P P ^a   Coville, P F ^a   Wanwimolruk, Sompon ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Cytochrome P450; Drug metabolising enzymes; Nitrosamine; Oesophageal tumour

Indexed keywords

4 NITROPHENOL HYDROXYLASE; ANTINEOPLASTIC AGENT; CYTOCHROME P450; CYTOCHROME P450 2D; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; DEBRISOQUINE 4 HYDROXYLASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; N BENZYL N METHYLNITROSAMINE; OXYGENASE; PHENACETIN; QUININE HYDROXYLASE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ESOPHAGUS TUMOR; FEMALE; LIVER MICROSOME METABOLISM; NONHUMAN; RAT;

EID: 0036380397     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2002.19.1.13     Document Type: Conference Paper

References (32)

1. Hecht SS, Hoffman D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Survey 1989; 8: 273-294.
2. Lijinsky W. Structure activity relations in carcinogenesis by N-nitroso compounds. Cancer Metast Rev 1987; 6: 301-356.
3. Mirivish SS. Role of N-nitrosocompounds (NOC) and N-nitrosation in etiology of gastric, oesophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995; 93: 17-48.
4. Druckrey H. Organospecific carcinogenesis in the digestive tract. In: Nakararaw W, Takayamas S, Sugimurat T, eds. Topics in Chemical Carcinogenesis. Baltimore, MD: University Park Press, 1972; 73: 105-112.
5. Schweinsberg F, Kouros M. Reactions of N-methyl N-nitrosobenzylamine and related substrates with enzyme-containing cell fractions isolated from various organs of rats and mice. Cancer Lett 1979; 7: 115-120.
6. Barch DH, Fox CC. Dietary ellagic acid reduces the oesophageal microsomal metabolism of methylbenzylnitrosamine. Cancer Lett 1989; 44: 39-44.
7. Day NE, Varghese C. Oesophageal cancer. Cancer Survey 1994; 19: 43-54.
8. Cook-Mazaffari P. The epidemiology of cancer of the oesophagus. Nutr Cancer 1979; 1: 51-60.
9. Murray GI, Weaver RJ, Paterson PJ, et al. Expression of xenobiotic metabolising enzymes in breast cancer. J Pathol 1993; 169: 347-353.
10. Lijinsky W. Chemistry and metabolism of N-nitrosocompounds related to respiratory tract carcinogenesis. In: Reznik-Schuller HM, ed. Comparative Respiratory Tract Carcinogenesis, Vol. II. Boca Raton, FL: CRC Press, 1983; 95-108.
11. Preussmann R, Wiessler M. The enigma of the organ specificity of carcinogenic nitrosamines. Trends Pharmacol Sci 1987; 8: 185-189.
12. White EH. The chemistry of N-alkyl-N-nitrosamine. Methods of preparation. J Am Chem Soc 1955; 77: 6008-6022.
13. Robson RA, Matthews AP, Miners JO, et al. Characterization of theophylline metabolism by human liver microsomes. Br J Clin Pharmacol 1987; 24: 293-300.
14. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
15. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 1964; 239: 2370-2379.
16. Tassaneeyakul W, Birkett DJ, Veronese ME, et al. Specificity of substrate and inhibitor probes for human cytochromes P4501A1 and 1A2. J Pharmacol Exp Ther 1993; 265: 401-407.
17. Wanwimolruk S, Wong SM, Zhang H, Coville PF. Simultaneous determination of quinine and a major metabolite 3-hydroxyquinine in biological fluid by HPLC without extraction. J Liq Chromatogr 1996; 19: 293-305.
18. Wanwimolruk S, Ferry DG. Rapid high-performance liquid chromatographic method for the analysis of debrisoquine and 4-hydroxydebrisoquine in urine without derivatisation. J Liq Chromatogr 1990; 13: 961-968.
19. Luquita MG, Sanchez Pozzi EJ, Cotania VA, Mottino AD. Analysis of p-nitrophenol glucurodination in hepatic microsomes from lactating rats. Biochem Pharmacol 1994; 47: 1179-1185.
20. Burchell B. Substrate specificity of UDP-glucuronyltransferase, purified to apparent homogeneity from phenobarbital treated rat liver. Biochem J 1974; 173: 749-757.
21. Habig WH, Pabst MJ, Jakob WB. Glutathione-S-transferase, the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
22. Dai WD, Lee V, Chin W, et al. DNA methylation in specific cells of rat liver by N-nitrosodimethylmine and N-nitrosomethylbenzylamine. Carcinogenesis 1991; 12: 1325-1329.
23. Labuc GE, Archer MC. Comparative tumour initiating activities of N-nitroso-methylbenzylamine and N-nitrosodimethylamine in rat liver. Carcinogenesis 1982; 3: 519-523.
24. Siddiqi M, Preussmann R. Oesophageal cancer in Kashmir - an assessment. J Cancer Res Clin Oncol 1989; 115: 111-117.
25. Pera M, Cardes A, Pera C, Mohr U. Nutritional aspects in oesophageal carcinogenesis. Anticancer Res 1987; 7: 301-308.
26. Kawanishi T, Ohno Y, Takanaka A, Kawano S, Yamzoe Y, Kato R, Omori Y. N-Nitrosodialkylamine dealkylation in reconstituted systems containing cytochrome P450 purified from phenobarbital and β-naphthoflavone-treated rats. Arch Toxicol 1992; 66: 137-142.
27. Norred WP, Nishie K, Keyl AC. Effects of short-term administration of nitrosamines on rat hepatic microsomal enzymes. Biochem Pharmacol 1975; 24: 1313-1316.
28. Habib SL, Badawi AF, Awey HA, Mostafa M. Modifications in the carcinogen-metabolising capacity of mouse liver treated with N-nitrosocompounds. Oncol Rep 1998; 5: 965-969.
29. Stoner GD, Siglin JC, Morse MA, Desai DH, Amin SG, Kresty LA, Tolburen AL, Heffer EM, Francis DJ. Enhancement of oesophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanate. Carcinogenesis 1995; 6: 2473-2476.
30. Degawa M, Miura S, Yoshinari K, Hashimoto Y. Altered expression of CYP1A enzymes in rat hepatocarcinogenesis. Jpn J Cancer Res 1995; 86: 535-539.
31. Kivisto KT, Kroemer HK, Eichelbaum M. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 1995; 40: 523-530.
32. Smith TJ, Liao A, Wang LD, Yang GY, Starcic S, Philbert MA, Yang CS. Characterisation of xenobiotic metabolising enzymes and nitrosamine metabolism in the human esophagus. Carcinogenesis 1998; 19: 667-672.